{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T21:18:52Z","timestamp":1792617532391,"version":"4.5.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T00:00:00Z","timestamp":1620259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T00:00:00Z","timestamp":1620259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s00520-021-06231-8","type":"journal-article","created":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T02:03:21Z","timestamp":1620266601000},"page":"6957-6972","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Effect of cytotoxic chemotherapy on bone health among breast cancer patients. Does it require intervention?"],"prefix":"10.1007","volume":"29","author":[{"given":"Yadav","family":"Nisha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9852-2525","authenticated-orcid":false,"given":"Biswajit","family":"Dubashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachariah","family":"Bobby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaya Prakash","family":"Sahoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smita","family":"Kayal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,6]]},"reference":[{"issue":"2","key":"6231_CR1","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4103\/2231-4040.72251","volume":"1","author":"GN Sharma","year":"2010","unstructured":"Sharma GN, Dave R, Sanadya J, Sharma P, Sharma KK (2010) Various types and management of breast cancer: an overview. J Adv Pharm Technol Res 1(2):109\u2013126","journal-title":"J Adv Pharm Technol Res"},{"issue":"3","key":"6231_CR2","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00774-015-0679-x","volume":"34","author":"C Fan","year":"2016","unstructured":"Fan C, Georgiou KR, McKinnon RA, Keefe DMK, Howe PRC, Xian CJ (2016) Combination chemotherapy with cyclophosphamide, epirubicin and 5-fluorouracil causes trabecular bone loss, bone marrow cell depletion and marrow adiposity in female rats. J Bone Miner Metab 34(3):277\u2013290","journal-title":"J Bone Miner Metab"},{"issue":"1","key":"6231_CR3","first-page":"245","volume":"22","author":"LJ Peppone","year":"2014","unstructured":"Peppone LJ, Mustian KM, Rosier RN, Carroll JK, Purnell JQ, Janelsins MC et al (2014) Bone health issues in breast cancer survivors: a Medicare current beneficiary survey (MCBS) study. Support Care Cancer Off J Multinatl Assoc Support Care Cancer 22(1):245\u2013251","journal-title":"Support Care Cancer Off J Multinatl Assoc Support Care Cancer"},{"issue":"4","key":"6231_CR4","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s00198-008-0721-0","volume":"20","author":"Z Chen","year":"2009","unstructured":"Chen Z, Maricic M, Aragaki AK, Mouton C, Arendell L, Lopez AM et al (2009) Fracture risk increases after diagnosis of breast or other cancers in postmenopausal women: results from the Women\u2019s Health Initiative. Osteoporos Int 20(4):527\u2013536","journal-title":"Osteoporos Int"},{"issue":"3","key":"6231_CR5","first-page":"233","volume":"31","author":"JA Siddiqui","year":"2016","unstructured":"Siddiqui JA, Partridge NC (2016) Physiological bone remodeling: systemic regulation and growth factor involvement. Physiol Bethesda Md 31(3):233\u2013245","journal-title":"Physiol Bethesda Md"},{"issue":"6","key":"6231_CR6","doi-asserted-by":"publisher","first-page":"846","DOI":"10.4103\/2230-8210.192914","volume":"20","author":"S Shetty","year":"2016","unstructured":"Shetty S, Kapoor N, Bondu J, Thomas N, Paul T (2016) Bone turnover markers: emerging tool in the management of osteoporosis. Indian J Endocrinol Metab 20(6):846","journal-title":"Indian J Endocrinol Metab"},{"issue":"3","key":"6231_CR7","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.ecl.2017.04.003","volume":"46","author":"CK Chew","year":"2017","unstructured":"Chew CK, Clarke BL (2017) Biochemical testing relevant to bone. Endocrinol Metab Clin North Am 46(3):649\u2013667","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"5","key":"6231_CR8","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s40620-017-0408-8","volume":"30","author":"MG Vervloet","year":"2017","unstructured":"Vervloet MG, Brandenburg VM, CKD-MBD working group of ERA-EDTA (2017) Circulating markers of bone turnover. J Nephrol 30(5):663\u201370","journal-title":"J Nephrol"},{"issue":"1","key":"6231_CR9","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/j.1447-0756.2008.00868.x","volume":"35","author":"LK Trento","year":"2009","unstructured":"Trento LK, Pietropolli A, Ticconi C, Gravotta E, De Martino MU, Fabbri A et al (2009) Role of type I collagen C telopeptide, bone-specific alkaline phosphatase and osteocalcin in the assessment of bone status in postmenopausal women. J Obstet Gynaecol Res 35(1):152\u2013159","journal-title":"J Obstet Gynaecol Res"},{"issue":"10","key":"6231_CR10","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1002\/jbmr.5650111021","volume":"11","author":"P Garnero","year":"1996","unstructured":"Garnero P, Hausherr E, Chapuy MC, Marcelli C, Grandjean H, Muller C et al (1996) Markers of bone resorption predict hip fracture in elderly women: the EPIDOS prospective study. J Bone Miner Res Off J Am Soc Bone Miner Res 11(10):1531\u20131538","journal-title":"J Bone Miner Res Off J Am Soc Bone Miner Res"},{"issue":"4","key":"6231_CR11","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1359\/jbmr.1999.14.4.518","volume":"14","author":"K Yano","year":"1999","unstructured":"Yano K, Tsuda E, Washida N, Kobayashi F, Goto M, Harada A et al (1999) Immunological characterization of circulating osteoprotegerin\/osteoclastogenesis inhibitory factor: increased serum concentrations in postmenopausal women with osteoporosis. J Bone Miner Res Off J Am Soc Bone Miner Res 14(4):518\u2013527","journal-title":"J Bone Miner Res Off J Am Soc Bone Miner Res"},{"issue":"11","key":"6231_CR12","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.steroids.2012.06.005","volume":"77","author":"AV Krishnan","year":"2012","unstructured":"Krishnan AV, Swami S, Feldman D (2012) The potential therapeutic benefits of vitamin D in the treatment of estrogen receptor positive breast cancer. Steroids 77(11):1107\u20131112","journal-title":"Steroids"},{"issue":"9","key":"6231_CR13","first-page":"3128","volume":"82","author":"A Tomkinson","year":"1997","unstructured":"Tomkinson A, Reeve J, Shaw RW, Noble BS (1997) The death of osteocytes via apoptosis accompanies estrogen withdrawal in human bone. J Clin Endocrinol Metab 82(9):3128\u20133135","journal-title":"J Clin Endocrinol Metab"},{"issue":"1\u20132","key":"6231_CR14","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.cellimm.2007.06.008","volume":"252","author":"R Pacifici","year":"2008","unstructured":"Pacifici R (2008) Estrogen deficiency, T cells and bone loss. Cell Immunol 252(1\u20132):68\u201380","journal-title":"Cell Immunol"},{"issue":"8","key":"6231_CR15","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1172\/JCI200317215","volume":"111","author":"G Eghbali-Fatourechi","year":"2003","unstructured":"Eghbali-Fatourechi G, Khosla S, Sanyal A, Boyle WJ, Lacey DL, Riggs BL (2003) Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. J Clin Invest 111(8):1221\u20131230","journal-title":"J Clin Invest"},{"issue":"1","key":"6231_CR16","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/ncponc0381","volume":"3","author":"JM Blair","year":"2006","unstructured":"Blair JM, Zhou H, Seibel MJ, Dunstan CR (2006) Mechanisms of disease: roles of OPG, RANKL and RANK in the pathophysiology of skeletal metastasis. Nat Clin Pract Oncol 3(1):41\u201349","journal-title":"Nat Clin Pract Oncol"},{"issue":"3","key":"6231_CR17","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1002\/(SICI)1097-4644(19991201)75:3<528::AID-JCB16>3.0.CO;2-3","volume":"75","author":"JM Janssen","year":"1999","unstructured":"Janssen JM, Bland R, Hewison M, Coughtrie MW, Sharp S, Arts J et al (1999) Estradiol formation by human osteoblasts via multiple pathways: relation with osteoblast function. J Cell Biochem 75(3):528\u2013537","journal-title":"J Cell Biochem"},{"issue":"10","key":"6231_CR18","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1007\/s00432-014-1726-z","volume":"140","author":"I Kyvernitakis","year":"2014","unstructured":"Kyvernitakis I, Rachner TD, Urbschat A, Hars O, Hofbauer LC, Hadji P (2014) Effect of aromatase inhibition on serum levels of sclerostin and dickkopf-1, bone turnover markers and bone mineral density in women with breast cancer. J Cancer Res Clin Oncol 140(10):1671\u20131680","journal-title":"J Cancer Res Clin Oncol"},{"issue":"7041","key":"6231_CR19","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1136\/bmj.312.7041.1254","volume":"312","author":"D Marshall","year":"1996","unstructured":"Marshall D, Johnell O, Wedel H (1996) Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 312(7041):1254\u20131259","journal-title":"BMJ"},{"issue":"3","key":"6231_CR20","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.bone.2007.11.001","volume":"42","author":"JA Kanis","year":"2008","unstructured":"Kanis JA, McCloskey EV, Johansson H, Oden A, Melton LJ, Khaltaev N (2008) A reference standard for the description of osteoporosis. Bone 42(3):467\u2013475","journal-title":"Bone"},{"issue":"2","key":"6231_CR21","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1359\/jbmr.081004","volume":"24","author":"C Berger","year":"2009","unstructured":"Berger C, Langsetmo L, Joseph L, Hanley DA, Davison KS, Josse RG et al (2009) Association between change in BMD and fragility fracture in women and men. J Bone Miner Res 24(2):361\u2013370","journal-title":"J Bone Miner Res"},{"issue":"1","key":"6231_CR22","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s11657-020-00756-x","volume":"15","author":"R Rajan","year":"2020","unstructured":"Rajan R, Paul J, Cherian KE, Asha HS, Kapoor N, Paul TV (2020) FRAX\u00ae with or without BMD and TBS predicts fragility fractures in community-dwelling rural southern Indian postmenopausal women. Arch Osteoporos 15(1):82","journal-title":"Arch Osteoporos"},{"key":"6231_CR23","first-page":"61","volume":"10","author":"S Tomasevic-Todorovic","year":"2018","unstructured":"Tomasevic-Todorovic S, Vazic A, Issaka A, Hanna F (2018) Comparative assessment of fracture risk among osteoporosis and osteopenia patients: a cross-sectional study. Open Access Rheumatol Res Rev 10:61\u201366","journal-title":"Open Access Rheumatol Res Rev"},{"issue":"1","key":"6231_CR24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11657-020-0688-9","volume":"15","author":"S Shetty","year":"2020","unstructured":"Shetty S, John B, Mohan S, Paul TV (2020) Vertebral fracture assessment by dual-energy X-ray absorptiometry along with bone mineral density in the evaluation of postmenopausal osteoporosis. Arch Osteoporos 15(1):25","journal-title":"Arch Osteoporos"},{"issue":"1","key":"6231_CR25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/0378-5122(96)01042-0","volume":"25","author":"M Iki","year":"1996","unstructured":"Iki M, Kajita E, Dohi Y, Nishino H, Kusaka Y, Tsuchida C et al (1996) Age, menopause, bone turnover markers and lumbar bone loss in healthy Japanese women. Maturitas 25(1):59\u201367","journal-title":"Maturitas"},{"issue":"2","key":"6231_CR26","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s00520-009-0645-z","volume":"18","author":"M Trinkaus","year":"2010","unstructured":"Trinkaus M, Simmons C, Myers J, Dranatisaris G, Clemons M (2010) Skeletal-related events (SREs) in breast cancer patients with bone metastases treated in the nontrial setting. Support Care Cancer 18(2):197\u2013203","journal-title":"Support Care Cancer"},{"issue":"2","key":"6231_CR27","doi-asserted-by":"publisher","first-page":"315","DOI":"10.2147\/CIA.S2539","volume":"3","author":"SF Vondracek","year":"2008","unstructured":"Vondracek SF, Minne P, McDermott MT (2008) Clinical challenges in the management of osteoporosis. Clin Interv Aging 3(2):315\u2013329","journal-title":"Clin Interv Aging"},{"issue":"4","key":"6231_CR28","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1097\/BOR.0b013e3283025e9c","volume":"20","author":"G Duque","year":"2008","unstructured":"Duque G (2008) Bone and fat connection in aging bone. Curr Opin Rheumatol 20(4):429\u2013434","journal-title":"Curr Opin Rheumatol"},{"issue":"5","key":"6231_CR29","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1007\/s00198-019-04843-9","volume":"30","author":"P Oura","year":"2019","unstructured":"Oura P, Auvinen J, Paananen M, Junno J-A, Niinim\u00e4ki J, Karppinen J et al (2019) Dairy- and supplement-based calcium intake in adulthood and vertebral dimensions in midlife-the Northern Finland Birth Cohort 1966 Study. OsteoporosInt J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA 30(5):985\u2013994","journal-title":"OsteoporosInt J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA"},{"issue":"2","key":"6231_CR30","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.cell.2006.01.051","volume":"125","author":"L Sun","year":"2006","unstructured":"Sun L, Peng Y, Sharrow AC, Iqbal J, Zhang Z, Papachristou DJ et al (2006) FSH directly regulates bone mass. Cell 125(2):247\u2013260","journal-title":"Cell"},{"issue":"10","key":"6231_CR31","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1634\/theoncologist.10-10-780","volume":"10","author":"S Gl\u00fcck","year":"2005","unstructured":"Gl\u00fcck S (2005) Adjuvant chemotherapy for early breast cancer: optimal use of epirubicin. Oncologist 10(10):780\u2013791","journal-title":"Oncologist"},{"issue":"4","key":"6231_CR32","doi-asserted-by":"publisher","first-page":"602","DOI":"10.2106\/00004623-198466040-00016","volume":"66","author":"GE Friedlaender","year":"1984","unstructured":"Friedlaender GE, Tross RB, Doganis AC, Kirkwood JM, Baron R (1984) Effects of chemotherapeutic agents on bone. I. Short-term methotrexate and doxorubicin (adriamycin) treatment in a rat model. J Bone Joint Surg Am 66(4):602\u20137","journal-title":"J Bone Joint Surg Am"},{"issue":"7","key":"6231_CR33","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1002\/jcp.23034","volume":"227","author":"T Shandala","year":"2012","unstructured":"Shandala T, Ng YS, Hopwood B, Yip Y-C, Foster BK, Xian CJ (2012) The role of osteocyte apoptosis in cancer chemotherapy-induced bone loss. J Cell Physiol 227(7):2889\u20132897","journal-title":"J Cell Physiol"},{"issue":"6","key":"6231_CR34","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1002\/jcb.20889","volume":"99","author":"CJ Xian","year":"2006","unstructured":"Xian CJ, Cool JC, Pyragius T, Foster BK (2006) Damage and recovery of the bone growth mechanism in young rats following 5-fluorouracil acute chemotherapy. J Cell Biochem 99(6):1688\u20131704","journal-title":"J Cell Biochem"},{"issue":"1","key":"6231_CR35","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s10549-017-4308-3","volume":"165","author":"C Fan","year":"2017","unstructured":"Fan C, Georgiou KR, Morris HA, McKinnon RA, Keefe DMK, Howe PR et al (2017) Combination breast cancer chemotherapy with doxorubicin and cyclophosphamide damages bone and bone marrow in a female rat model. Breast Cancer Res Treat 165(1):41\u201351","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"6231_CR36","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s00774-008-0013-y","volume":"27","author":"M Takahashi","year":"2009","unstructured":"Takahashi M, Mizoguchi T, Uehara S, Nakamichi Y, Yang S, Naramoto H et al (2009) Docetaxel inhibits bone resorption through suppression of osteoclast formation and function in different manners. J Bone Miner Metab 27(1):24\u201335","journal-title":"J Bone Miner Metab"},{"issue":"3","key":"6231_CR37","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1002\/jcb.23423","volume":"113","author":"ESM Ang","year":"2012","unstructured":"Ang ESM, Pavlos NJ, Chim SM, Feng HT, Scaife RM, Steer JH et al (2012) Paclitaxel inhibits osteoclast formation and bone resorption via influencing mitotic cell cycle arrest and RANKL-induced activation of NF-\u03baB and ERK. J Cell Biochem 113(3):946\u2013955","journal-title":"J Cell Biochem"},{"issue":"6","key":"6231_CR38","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1053\/j.seminoncol.2003.08.028","volume":"30","author":"B Ramaswamy","year":"2003","unstructured":"Ramaswamy B, Shapiro CL (2003) Osteopenia and osteoporosis in women with breast cancer. Semin Oncol 30(6):763\u2013775","journal-title":"Semin Oncol"},{"issue":"18","key":"6231_CR39","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.1016\/j.ejca.2009.09.026","volume":"45","author":"P Hadji","year":"2009","unstructured":"Hadji P, Ziller M, Maskow C, Albert U, Kalder M (2009) The influence of chemotherapy on bone mineral density, quantitative ultrasonometry and bone turnover in pre-menopausal women with breast cancer. Eur J Cancer 45(18):3205\u20133212","journal-title":"Eur J Cancer"},{"issue":"7","key":"6231_CR40","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1089\/jwh.1.1999.8.949","volume":"8","author":"EE Lower","year":"1999","unstructured":"Lower EE, Blau R, Gazder P, Tummala R (1999) The risk of premature menopause induced by chemotherapy for early breast cancer. J Womens Health Gend Based Med 8(7):949\u2013954","journal-title":"J Womens Health Gend Based Med"},{"issue":"5","key":"6231_CR41","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1200\/JCO.1996.14.5.1718","volume":"14","author":"J Bines","year":"1996","unstructured":"Bines J, Oleske DM, Cobleigh MA (1996) Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol Off J Am Soc Clin Oncol 14(5):1718\u20131729","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"14","key":"6231_CR42","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.1200\/JCO.2001.19.14.3306","volume":"19","author":"CL Shapiro","year":"2001","unstructured":"Shapiro CL, Manola J, Leboff M (2001) Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancer. J Clin Oncol Off J Am Soc Clin Oncol 19(14):3306\u20133311","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"3","key":"6231_CR43","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s10549-010-0899-7","volume":"123","author":"DA Cameron","year":"2010","unstructured":"Cameron DA, Douglas S, Brown JE, Anderson RA (2010) Bone mineral density loss during adjuvant chemotherapy in pre-menopausal women with early breast cancer: is it dependent on oestrogen deficiency? Breast Cancer Res Treat 123(3):805\u2013814","journal-title":"Breast Cancer Res Treat"},{"issue":"12","key":"6231_CR44","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1007\/s00198-003-1508-y","volume":"14","author":"I Fogelman","year":"2003","unstructured":"Fogelman I, Blake GM, Blamey R, Palmer M, Sauerbrei W, Schumacher M et al (2003) Bone mineral density in premenopausal women treated for node-positive early breast cancer with 2 years of goserelin or 6 months of cyclophosphamide, methotrexate and 5-fluorouracil (CMF). Osteoporos Int 14(12):1001\u20131006","journal-title":"Osteoporos Int"},{"issue":"18","key":"6231_CR45","doi-asserted-by":"publisher","first-page":"3694","DOI":"10.1200\/JCO.2004.08.148","volume":"22","author":"\u00c1 Sverrisd\u00f3ttir","year":"2004","unstructured":"Sverrisd\u00f3ttir \u00c1, Fornander T, Jacobsson H, von Schoultz E, Rutqvist LE (2004) Bone mineral density among premenopausal women with early breast cancer in a randomized trial of adjuvant endocrine therapy. J Clin Oncol 22(18):3694\u20133699","journal-title":"J Clin Oncol"},{"issue":"1","key":"6231_CR46","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s10549-005-3803-0","volume":"93","author":"L-M Rodr\u00edguez-Rodr\u00edguez","year":"2005","unstructured":"Rodr\u00edguez-Rodr\u00edguez L-M, Rodr\u00edguez-Rodr\u00edguez E-M, Oramas-Rodr\u00edguez J-M, Santolaria-Fernandez F, Llanos M, Cruz J et al (2005) Changes on bone mineral density after adjuvant treatment in women with non-metastatic breast cancer. Breast Cancer Res Treat 93(1):75\u201383","journal-title":"Breast Cancer Res Treat"},{"key":"6231_CR47","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1186\/s12885-016-2905-x","volume":"16","author":"K Monroy-Cisneros","year":"2016","unstructured":"Monroy-Cisneros K, Esparza-Romero J, Valencia ME, Guevara-Torres AG, M\u00e9ndez-Estrada RO, Anduro-Corona I et al (2016) Antineoplastic treatment effect on bone mineral density in Mexican breast cancer patients. BMC Cancer 16:1860","journal-title":"BMC Cancer"},{"issue":"10","key":"6231_CR48","first-page":"4229","volume":"24","author":"C\u00d8 Christensen","year":"2016","unstructured":"Christensen C\u00d8, Cronin-Fenton D, Fr\u00f8slev T, Hermann AP, Ewertz M (2016) Change in bone mineral density during adjuvant chemotherapy for early-stage breast cancer. Support Care Cancer Off J Multinatl Assoc Support Care Cancer 24(10):4229\u20134236","journal-title":"Support Care Cancer Off J Multinatl Assoc Support Care Cancer"},{"issue":"2","key":"6231_CR49","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1097\/NCC.0000000000000586","volume":"42","author":"SH Kim","year":"2019","unstructured":"Kim SH, Cho YU, Kim SJ, Han MS (2019) Changes in bone mineral density in women with breast cancer: a prospective cohort study. Cancer Nurs 42(2):164\u2013172","journal-title":"Cancer Nurs"},{"issue":"402","key":"6231_CR50","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.mce.2014.12.028","volume":"15","author":"DR Oostra","year":"2015","unstructured":"Oostra DR, Lustberg MB, Reinbolt RE, Pan X, Wesolowski R, Shapiro CL (2015) Association of osteoprotegerin and bone loss after adjuvant chemotherapy in early-stage breast cancer. Mol Cell Endocrinol 15(402):51\u201356","journal-title":"Mol Cell Endocrinol"},{"issue":"2C","key":"6231_CR51","first-page":"1271","volume":"24","author":"MEH Kailaj\u00e4rvi","year":"2004","unstructured":"Kailaj\u00e4rvi MEH, Salminen EK, Paija OMM, Virtanent AM, Leino AE, Irjala KA (2004) Serum bone markers in breast cancer patients during 5-fluorouracil, epirubicin and cyclophosphamide (FEC) therapy. Anticancer Res 24(2C):1271\u20131274","journal-title":"Anticancer Res"},{"issue":"2","key":"6231_CR52","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s10549-012-2084-7","volume":"134","author":"W Jacot","year":"2012","unstructured":"Jacot W, Pouderoux S, Thezenas S, Chapelle A, Bleuse J-P, Romieu G et al (2012) Increased prevalence of vitamin D insufficiency in patients with breast cancer after neoadjuvant chemotherapy. Breast Cancer Res Treat 134(2):709\u2013717","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"6231_CR53","doi-asserted-by":"publisher","first-page":"e0126053","DOI":"10.1371\/journal.pone.0126053","volume":"10","author":"Y Chen","year":"2015","unstructured":"Chen Y, Xu G, Yang F (2015) Effect of neoadjuvant chemotherapy on the serum levels of bone turnover markers in women with early-stage breast cancer. PLoS One 10(4):e0126053","journal-title":"PLoS One"},{"issue":"11","key":"6231_CR54","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.6061\/clinics\/2012(11)16","volume":"67","author":"MM Madureira","year":"2012","unstructured":"Madureira MM, Ciconelli RM, Pereira RMR (2012) Quality of life measurements in patients with osteoporosis and fractures. Clinics 67(11):1315\u20131320","journal-title":"Clinics"},{"issue":"2","key":"6231_CR55","first-page":"239","volume":"14","author":"Y Turan","year":"2009","unstructured":"Turan Y, Kocaaga Z, Karakoyun-Celik O, Gurgan A, Duransoy A (2009) Osteoporosis in women with breast cancer and its effect on quality of life: a pilot study. J BUON 14(2):239\u2013243","journal-title":"J BUON"},{"issue":"12","key":"6231_CR56","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1016\/j.annonc.2020.07.019","volume":"31","author":"R Coleman","year":"2020","unstructured":"Coleman R, Hadji P, Body J-J, Santini D, Chow E, Terpos E et al (2020) Bone health in cancer: ESMO clinical practice guidelines. Ann Oncol Off J EurSoc Med Oncol 31(12):1650\u20131663","journal-title":"Ann Oncol Off J EurSoc Med Oncol"},{"key":"6231_CR57","doi-asserted-by":"crossref","unstructured":"Gralow JR, Biermann JS, Farooki A, Fornier MN, Gagel RF, Kumar R, et al (2013) NCCN task force report: bone health in cancer care. J Natl Compr Cancer Netw JNCCN 11(Suppl 3):S1\u201350. quiz S51.","DOI":"10.6004\/jnccn.2013.0215"},{"key":"6231_CR58","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2147\/JEP.S7823","volume":"2","author":"J Waalen","year":"2010","unstructured":"Waalen J (2010) Current and emerging therapies for the treatment of osteoporosis. J Exp Pharmacol 2:121\u2013134","journal-title":"J Exp Pharmacol"},{"issue":"30","key":"6231_CR59","doi-asserted-by":"publisher","first-page":"3665","DOI":"10.1200\/JCO.2012.42.2097","volume":"30","author":"MB Lustberg","year":"2012","unstructured":"Lustberg MB, Reinbolt RE, Shapiro CL (2012) Bone health in adult cancer survivorship. J Clin Oncol Off J Am Soc Clin Oncol 30(30):3665\u20133674","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"5","key":"6231_CR60","first-page":"683","volume":"47","author":"CL Shapiro","year":"2011","unstructured":"Shapiro CL, Halabi S, Hars V, Archer L, Weckstein D, Kirshner J et al (2011) Zoledronic acid preserves bone mineral density in premenopausal women who develop ovarian failure due to adjuvant chemotherapy: final results from CALGB trial 79809. Eur J Cancer Oxf Engl 1990 47(5):683\u20139","journal-title":"Eur J Cancer Oxf Engl 1990"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-021-06231-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-021-06231-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-021-06231-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T06:52:24Z","timestamp":1725000744000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-021-06231-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,6]]},"references-count":60,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["6231"],"URL":"https:\/\/doi.org\/10.1007\/s00520-021-06231-8","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,6]]},"assertion":[{"value":"11 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}